• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性睾丸癌:英国家族登记报告、风险评估及 HLA Ⅰ类同胞对分析

Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

作者信息

Forman D, Oliver R T, Brett A R, Marsh S G, Moses J H, Bodmer J G, Chilvers C E, Pike M C

机构信息

ICRF Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford, UK.

出版信息

Br J Cancer. 1992 Feb;65(2):255-62. doi: 10.1038/bjc.1992.51.

DOI:10.1038/bjc.1992.51
PMID:1739626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1977724/
Abstract

Forty-two families with two or more cases of testicular cancer have been reported to the UK Register for Familial Testicular Cancer, comprising two pairs of identical twins, 27 sets of other brothers (25 pairs, two triples), nine father-son pairs, two pairs of first cousins and two uncle-nephew pairs. In total 91 testicular tumours are described in 86 individuals (42 (46%) pure seminoma, 49 (54%) other germ cell tumours). The median age at diagnosis in these patients was significantly younger than that in a comparable series of non-familial patients (29 c.f. 32.5 years, P less than 0.01). In a case-control comparison of 794 testicular cancer patients, eight patients (1.0%) had a brother and four patients (0.5%) had a father with a previous diagnosis of testicular cancer at the time of their own diagnosis (and these families are all included in this report). Two out of 794 controls (0.3%) had a first degree relative with testicular cancer. The cumulative risk to a brother of a patient for developing testicular cancer by the age of 50 years was estimated to be 2.2% (95% C.I. 0.6-3.8%) which results in a relative risk of 9.8 (95% C.I. 2.8-16.7) in comparison with the general population. HLA Class I typing of 21 affected sib-pairs demonstrated four (19%) sharing two haplotypes, 13 pairs (62%) sharing one and four pairs (19%) sharing none. This did not differ significantly from the expected proportions of 25%/50%/25%. It is unlikely, therefore, that there is a major gene associated with testicular cancer predisposition within or closely linked to the major histocompatibility gene complex on chromosome 6.

摘要

已有42个家庭向英国家族性睾丸癌登记处报告了两例或更多例睾丸癌病例,其中包括两对同卵双胞胎、27组其他兄弟(25对,两组三胞胎)、9对父子、两对第一代堂兄弟以及两对叔侄。总共86人患有91例睾丸肿瘤(42例(46%)为纯精原细胞瘤,49例(54%)为其他生殖细胞肿瘤)。这些患者的诊断中位年龄明显低于一组类似的非家族性患者(29岁对比32.5岁,P小于0.01)。在一项对794例睾丸癌患者的病例对照研究中,8例患者(1.0%)有兄弟患过睾丸癌,4例患者(0.5%)有父亲在其自身诊断时曾被诊断为睾丸癌(这些家庭均包含在本报告中)。794名对照中有2例(0.3%)有患睾丸癌的一级亲属。据估计,患者的兄弟在50岁前患睾丸癌的累积风险为2.2%(95%置信区间0.6 - 3.8%),与一般人群相比,相对风险为9.8(95%置信区间2.8 - 16.7)。对21对患病同胞进行的HLA I类分型显示,4对(19%)共享两个单倍型,13对(62%)共享一个,4对(19%)无共享。这与预期比例25%/50%/25%无显著差异。因此,不太可能在6号染色体上的主要组织相容性基因复合体内或与之紧密连锁存在与睾丸癌易感性相关的主要基因。

相似文献

1
Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.家族性睾丸癌:英国家族登记报告、风险评估及 HLA Ⅰ类同胞对分析
Br J Cancer. 1992 Feb;65(2):255-62. doi: 10.1038/bjc.1992.51.
2
HLA typing in familial testicular cancer.家族性睾丸癌中的人类白细胞抗原分型
Eur Urol. 1989;16(5):361-5. doi: 10.1159/000471617.
3
Familial testicular cancer in a single-centre population.
Eur J Cancer. 1999 Sep;35(9):1368-73. doi: 10.1016/s0959-8049(99)00140-9.
4
Testicular germ cell tumors in HLA-genotype non-twin brothers.
Urology. 1988 Oct;32(4):315-9. doi: 10.1016/0090-4295(88)90233-6.
5
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.基于组织学类型和诊断时年龄的睾丸癌患者亲属的癌症风险:来自五个北欧国家的联合研究。
Eur Urol. 2015 Aug;68(2):283-9. doi: 10.1016/j.eururo.2014.12.031. Epub 2015 Apr 23.
6
Testicular cancer in father and son.
Int J Urol. 1996 Jan;3(1):70-3. doi: 10.1111/j.1442-2042.1996.tb00635.x.
7
Familial testicular cancer in Norway and southern Sweden.挪威和瑞典南部的家族性睾丸癌。
Br J Cancer. 1996 Apr;73(7):964-9. doi: 10.1038/bjc.1996.173.
8
Familial risk in testicular cancer as a clue to a heritable and environmental aetiology.睾丸癌的家族风险是遗传和环境病因的线索。
Br J Cancer. 2004 May 4;90(9):1765-70. doi: 10.1038/sj.bjc.6601714.
9
Familial risks in testicular cancer as aetiological clues.睾丸癌的家族风险作为病因线索
Int J Androl. 2006 Feb;29(1):205-10. doi: 10.1111/j.1365-2605.2005.00599.x.
10
Familial testicular cancer: report of six cases and review of the literature.
Mayo Clin Proc. 1990 Jun;65(6):804-8. doi: 10.1016/s0025-6196(12)62570-1.

引用本文的文献

1
Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.青少年和年轻成人生殖细胞肿瘤:流行病学、基因组学、治疗和生存。
J Clin Oncol. 2024 Feb 20;42(6):696-706. doi: 10.1200/JCO.23.01099. Epub 2023 Oct 11.
2
Genetics of testicular germ cell tumors.睾丸生殖细胞肿瘤的遗传学
Curr Opin Urol. 2019 Jul;29(4):344-349. doi: 10.1097/MOU.0000000000000642.
3
Family history of cancer and risk of paediatric and young adult's testicular cancer: A Norwegian cohort study.癌症家族史与儿童和青年期睾丸癌风险:一项挪威队列研究。
Br J Cancer. 2019 May;120(10):1007-1014. doi: 10.1038/s41416-019-0445-2. Epub 2019 Apr 10.
4
Update on epidemiologic considerations and treatment trends in testicular cancer.睾丸癌的流行病学考量及治疗趋势的最新进展
Curr Opin Urol. 2018 Sep;28(5):440-447. doi: 10.1097/MOU.0000000000000532.
5
Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.BAK1、SPRY4和GAB2基因变异与儿童生殖细胞肿瘤相关:来自儿童肿瘤学组的报告
Genes Chromosomes Cancer. 2017 Jul;56(7):548-558. doi: 10.1002/gcc.22457. Epub 2017 Apr 4.
6
Testicular germ cell tumor genomics.睾丸生殖细胞肿瘤基因组学
Curr Opin Urol. 2017 Jan;27(1):41-47. doi: 10.1097/MOU.0000000000000347.
7
The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.睾丸生殖细胞肿瘤的基因组景观:从易感性到治疗。
Nat Rev Urol. 2016 Jul;13(7):409-19. doi: 10.1038/nrurol.2016.107. Epub 2016 Jun 14.
8
Rare inactivating PDE11A variants associated with testicular germ cell tumors.与睾丸生殖细胞肿瘤相关的罕见PDE11A失活变体。
Endocr Relat Cancer. 2015 Dec;22(6):909-17. doi: 10.1530/ERC-15-0034.
9
Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.家族性睾丸癌队列中前瞻性确定的偶发性睾丸癌风险
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1614-21. doi: 10.1158/1055-9965.EPI-14-1240. Epub 2015 Aug 11.
10
Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families.来自多例睾丸生殖细胞肿瘤(TGCT)家族的TGCT患者亲属中的非睾丸癌
Cancer Med. 2015 Jul;4(7):1069-78. doi: 10.1002/cam4.450. Epub 2015 Apr 17.

本文引用的文献

1
Father-son testicular malignancy. Does genetic anticipation occur?
Cancer. 1980 Mar 1;45(5):1005-9. doi: 10.1002/1097-0142(19800301)45:5<1005::aid-cncr2820450529>3.0.co;2-0.
2
HLA antigens in patients with germ cell cancers of the testis.睾丸生殖细胞癌患者的人类白细胞抗原(HLA)
Cancer Res. 1982 Jun;42(6):2470-3.
3
The investigation of linkage between a quantitative trait and a marker locus.数量性状与标记位点之间的连锁研究。
Behav Genet. 1972 Mar;2(1):3-19. doi: 10.1007/BF01066731.
4
Familial tumor of the testis.
Eur Urol. 1986;12(2):104-8. doi: 10.1159/000472592.
5
Abnormal sexual differentiation and neoplasia.
Cancer Genet Cytogenet. 1987 Apr;25(2):191-218. doi: 10.1016/0165-4608(87)90180-4.
6
HLA association of testicular seminoma.睾丸精原细胞瘤的人类白细胞抗原相关性
Klin Wochenschr. 1988 Apr 15;66(8):337-9. doi: 10.1007/BF01735790.
7
Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature.
Oncology. 1987;44(6):367-77. doi: 10.1159/000226513.
8
Testicular germ cell tumors in HLA-genotype non-twin brothers.
Urology. 1988 Oct;32(4):315-9. doi: 10.1016/0090-4295(88)90233-6.
9
Bilateral testicular germ cell tumors. Report of nine cases and review of the literature.双侧睾丸生殖细胞肿瘤。9例报告并文献复习
Cancer. 1986 Mar 15;57(6):1254-8. doi: 10.1002/1097-0142(19860315)57:6<1254::aid-cncr2820570632>3.0.co;2-2.
10
Testicular neoplasms occurring in four brothers. A search for a genetic predisposition.
Cancer. 1985 May 1;55(9):2005-9. doi: 10.1002/1097-0142(19850501)55:9<2005::aid-cncr2820550930>3.0.co;2-l.